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and John R. Pluske1
Abstract
Background: Three experiments were conducted to examine the overall hypothesis that addition of medium chain
triglycerides (MCT) and cysteamine hydrochloride (CSH) into the diets of young and growing pigs would stimulate
the endogenous somatotropic axis to improve growth and performance.
Results: In Experiment 1, weaner pigs were given either a 5 d dietary supplement of 5 % MCT (n = 8) or a control
diet (n = 8). MCT increased the plasma concentration of growth hormone (GH; P < 0.05) and the GH secretagogue,
ghrelin (P < 0.05). Additionally, the MCT treatment reduced scouring (P < 0.05), maintained villous height in the
small intestine (P < 0.05) and stabilised daily weight gain (P < 0.05), compared to the controls. Experiment 2
compared the effects of 4 levels (0, 1, 3 and 6 % v/v) of MCT supplementation in grower-finisher male pigs, of
approximately 35 kg live weight (n = 15 per treatment). Blood samples taken after 7 wk of treatment showed that
the MCT supplementation increased circulating ghrelin (P < 0.001), GH (P < 0.01) and insulin (P < 0.05)
concentrations in a dose-dependent manner. Daily weight gain, feed intake and feed conversion ratio were not
affected by the MCT diets. In Experiment 3, 64 female pigs of approximately 60 kg live weight were allocated to
one of three dietary treatments: control (n = 20); 6 % MCT (n = 21); and 70 mg/kg CSH (n = 21). After 3 wk of
supplementation, the MCT treated pigs had a higher plasma concentration of ghrelin compared to the control and
CSH pigs (P < 0.05). Plasma concentrations of GH and weight were not affected by any of the dietary treatments.
Conclusions: Evidence is provided in Experiment 1 to support the use of dietary MCT supplements, perhaps acting
via stimulation of somatotropic endocrine pathways, to minimise weaning-associated disorders such as slowing of
growth and diarrhoea. In Experiments 2 and 3, although there was no effect on weight gain or feed conversion
ratio in either experiment, MCT and CSH increased endocrine components of the somatotropic axis.
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Background
Porcine somatotropin (growth hormone; GH), is approved
for use in pigs in many countries worldwide [1], although
not in the USA or European Union, to improve daily
weight gain and promote lean growth. Growth hormone is
a protein whose secretion from the somatotrophs of the
anterior pituitary gland is regulated by two hypothalamic
neurohormones that specifically act to either stimulate
(via GH-releasing hormone, GHRH) or inhibit (via
somatostatin) the release of GH [2]. The overall effects of
GH are to enhance the ability of muscle cells to utilise
nutrients, while simultaneously coordinating other physio-
logical processes and tissues (such as adipose tissue), in a
manner that supports enhanced lean growth [2].
Previous studies have investigated dietary means of
increasing endogenous GH levels. Dietary inclusion of
the sulfhydryl compound, cysteamine hydrochloride
(CSH), increases GH secretion in rats [3], sheep [4, 5]
and fish [6]. The increase in GH secretion is due to the
inhibitory effect of CSH on somatostatin release [5].
Dietary supplementations of CSH at 30 mg/kg and
50 mg/kg of feed resulted in significant increases in
daily weight gain in finisher pigs, but had no effect on
plasma concentrations of GH [7]. A dietary supplemen-
tation of CSH at 70 mg/kg of feed in finisher gilts
caused an increase in daily weight gain, but GH levels
were not measured in this study [8].
Ghrelin, a GH-releasing peptide initially isolated from
the stomach of rats [9], stimulates GH release from the
anterior pituitary gland [10]. Studies have identified
multiple physiological functions for ghrelin in mammals,
including GH release, appetite stimulation, cellular prolifer-
ation, apoptosis inhibition, and regulation of lipid metabol-
ism and tissue fat distribution in muscle [11–15]. Ghrelin is
also reported to be involved in the inhibition of pro-
inflammatory cytokine production and gastroprotection
against stress-induced gastric damage in rats [16, 17].
Moreover, Salfen et al. [18] showed that ghrelin infusion for
5 d increased GH secretion and concomitantly increased
weight gain in weaner pigs. The major active form of
ghrelin is a 28-amino acid peptide containing an octanoic
(C8:0) fatty acid on the third amino acid (serine) of the
peptide [19]. The post-translational C8 modification is
essential for biological activity of ghrelin to allow binding to
its receptor, which causes the release of GH at the level of
the pituitary [19]. It has been reported that ingested
medium chain triglyceride (MCT) oil derived from coco-
nuts, which contain high levels of octanoic acid, are directly
utilised for the bio-activation of ghrelin in rats [19]. How-
ever, no studies to date in pigs have looked at the effect of
dietary MCT on somatotropic growth responses and the
involvement of bioactive ghrelin levels in the circulation.
Three experiments were conducted to examine the
overall hypothesis that addition of MCT and CSH into
the diets of young and growing pigs would stimulate
the endogenous somatotropic axis to improve growth
and performance. The aims of Experiment 1 were to
investigate whether the addition of MCT to the diet of
weaner pigs would increase the biological activation of
ghrelin in the circulation, and if increasing the amount
of biologically-active ghrelin would promote GH release.
The aim of Experiment 2 was to determine the optimal
inclusion rate of MCT into the diets of grower-finisher
pigs to investigate somatotropic growth responses, and in
Experiment 3, a comparison of the effects of MCT with a
CSH dietary supplement for grower-finisher pigs was
conducted.
Methods
These experiments were approved by the Animal Ethics
Committees at both Murdoch University (NS1176/06,
NS2173/08, NS2253/09) and the Department of Agricul-
ture and Food WA (5-05-33, 2-08-9, 2-09-18) to ensure
compliance with the guidelines of the Australian Code
of Practice for the Care and Use of Animals for Scientific
Purposes. All experiments were conducted at the Medina
Research Station, Department of Agriculture and Food
WA, Medina, WA, Australia.
Experiment 1
Twenty four, 21-day-old Large White x Landrace pigs
(12 females and 12 intact males), with an average body
mass of 5.12 ± 0.24 kg (S.E.M.), were initially allocated
into 2 indoor pens (12 pigs per pen) measuring 1.5 m ×
1.5 m, and the indoor pens were kept at a constant
temperature of 28 °C. The pigs remained in these group
pens for 5 d to acclimatize to the post-weaning artificial
milk diet. Each pen contained a nipple drinker for water
and two milk drinkers.
During the 5 d of acclimatization, the pigs were pro-
vided with a commercial artificial milk diet prepared from
Pigiplus® (Biostarch P/L, Wendouree. Vic., Australia), as
per instructions, with the addition of 50 g of dried bovine
colostrum (Nufarm Colostrums, Laverton, Vic., Australia)
and 50 mL of a probiotic (Pro B, Dandenong, Vic.,
Australia) per 8 L of Pigiplus ®. Pigiplus ® contains approxi-
mately 14 % fat (as solids when reconstituted), 22 %
protein, 43 % lactose and 0.2 % fibre. At 2-h intervals the
milk feeders were cleaned and fresh milk added.
After the acclimatization period, 16 pigs (8 males and 8
females) were chosen for the experiment based on their
health status (e.g., normal feed intake, normal weight gain,
no or minimal scouring). These pigs were separated into
single indoor pens of 1.5 m × 0.75 m containing a nipple
water drinker and a milk drinker. The pigs were then
randomly allocated to the 2 treatments, ensuring that
there were equal numbers of each sex, similar sibling
relationships and similar group weights between the
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treatments. The two treatments were a Control group fed
a milk replacer diet (n = 8; Pigiplus®) and a MCT group
fed the same milk replacer with the addition of 5 % (v/v of
prepared milk replacer) MCT (MCT Oil; Melrose Labora-
tories Pty Ltd, Mitcham, Vic., Australia) (n = 8) in an
homogenous solution. The MCT oil supplement was a
refined form of coconut oil containing octanoic acid (C8)
(65–75 %), decanoic acid (C10) (25–35 %), and hexanoic
acid (C6) (<1 %). The diets were fed at isoenergetic levels
with the addition of 4.7 % (v/v) canola oil to the control
diet. Treatments continued for 5 d. Live weight and feed
refusals were measured daily. During the experiment, the
same staff member observed the pigs twice daily, 09:00 h
and 15:00 h, for clinical signs of diarrhoea. A pig was
recorded as having diarrhoea on a particular day if, at
either of the two daily time-points, fresh, loose faeces were
adhered to the perineal region of the pig, or if there was
observation of loose faeces during defecation.
Immediately prior to the start of the treatments and
on d 5, a single blood sample (1 mL) was obtained from
all pigs by venepuncture of the superior vena cava. Blood
was collected into EDTA vacutainers, immediately cen-
trifuged, an aliquot of the plasma was acidified with 1 %
(v/v) HCl for prevention of ghrelin degradation, and all
samples stored immediately at -20 °C.
The pigs were euthanized at the start of d 6 with a
lethal dose of Valabarb® (Pentobarbitone Sodium,
Jurox Ptd Ltd, NSW, Australia), and tissue samples
were collected from various regions of the small intestine
(duodenum, jejunum and ileum). These tissues were fixed
in Bouin’s solution for 6 h before being processed into
wax blocks and sectioned at 5 μm using a microtome for
histology. Six sections from each tissue, taken at 200 μm
intervals, were stained with haematoxylin and eosin.
Measurements of villous height and crypt depth were
made on the H&E stained slides using the method previ-
ously described by Pluske et al. [20]. For each tissue
section quantification of villous height and crypt depth
was carried out over ten randomly selected fields of view;
this approach has previously been shown to be sufficient
to stabilise the mean and variance of results [21].
Experiment 2
From 14 to 22 wk of age, 60 entire male Large White
x Landrace pigs (n = 15 per treatment) kept in individ-
ual grower pens received a standard commercial diet (con-
trol), or one of three MCT (MCT Oil; Melrose
Laboratories Pty Ltd, Mitcham, Vic., Australia) dietary
incorporation rates (1, 3 and 6 %). The diets were adjusted
to isoenergetic levels with canola oil, and contained
adequate energy, protein and lysine (based on wheat and
soybean meal) as lysine has been shown to be essential for
a GH increase to have an effect [22]. Live weight and feed
refusals were recorded daily. At wk 17 (after 21 d on the
dietary treatments), a subgroup of pigs (n = 6 per treat-
ment; selected on the basis of growth rate to reflect the
group average) had temporary catheters inserted in the
vein maxillaris by means of insertion of the catheter
through an ear vein (auricularis lateralis or auricularis
rostralis). The ear vein cannulation technique was
similar to that described in detail by Zanella and Mendl
[23]. Catheters were kept patent in between blood sam-
plings by flushing with approximately 1 mL of 5 IU/mL
heparin solution in sterile saline (0.9 % w/v Baxter
Healthcare, QLD, Australia). The day following cannu-
lation, repeated blood samples (1 mL) were collected at
15-min intervals for 4 h into EDTA-tubes. Initially,
2 mL of blood was withdrawn at each sampling, which
was then discarded to avoid dilution of the 1 mL
sample with the previous saline flush. The blood tubes
were immediately centrifuged, and 200 μL aliquots of
the 15 min plasma samples from each animal were
pooled, to account for the episodic secretion of GH,
and acidified with 1 % (v/v) HCl and immediately
stored at -20 °C. Pooled samples were used for hor-
mone analysis.
Experiment 3
This experiment used 62 crossbred (Large White x
Landrace) female pigs that were acclimatised and
grown in individual grower pens from an approximate
age of 10 wk post partum on a commercial diet until
16 wk of age when they were placed into their dietary
treatments. The pigs were weighed, ear-tagged, and al-
located at random to 3 treatments consisting of: a con-
trol group (commercial diet); a 6 % MCT dietary
supplement group (based on the findings of Experiment
2); and a CSH (cysteamine hydrochloride) supplement
group, with 21 pigs allocated to each treatment (20 in
the control group). The CSH (Porcimax™; Walcom Bio-
Chem Co. Ltd, Shanghai, China) was incorporated into
the feed at a dose of 70 mg/kg of feed. Live weight was
recorded weekly, and feed refusals were recorded daily.
At 19 wk post-partum, blood samples were taken from
a sub-group of 7 animals per treatment, selected based
on growth rates to reflect the group average. The ear
vein catherisation and blood sampling protocols used
were as described for Experiment 2. At the end of the ex-
periment the pigs were sent to a commercial abattoir (Lin-
ley Valley Pork, WA, Australia) once they had reached an
appropriate slaughter weight (95 ± 5 kg), where subcuta-
neous P2 backfat depth, hot carcass weight and carcass
dressing percentage were recorded. Depth of backfat at
the P2 site (6.5 cm from the midline over the last rib) was
measured on the slaughter line using a Hennessy Grading
Probe 4 (Hennessy Grading Systems Limited, Auckland,
New Zealand).
Miller et al. Journal of Animal Science and Biotechnology  (2016) 7:61 Page 3 of 12
Hormone analysis
Plasma collected in Experiments 1, 2 and 3 was analysed
for acyl-ghrelin, GH, IGF-1 and insulin. Acyl-ghrelin was
determined using an ELISA kit (Acyl Ghrelin (active)
EZGRA – 88 K, Lot 1635980, Millipore, Billerica MA
USA). The sensitivity of the assay was 25 pg/mL with
intra-assay and inter-assay precision of 3.8 % (CV) and
7.5 % (CV), respectively. GH was determined using an
ELISA kit (Active GH DSL 10-72100, Lot 891185, Diagnos-
tic Systems Laboratories Inc., Texas USA). The sensitivity
of the assay was 0.54 ng/mL with intra-assay and inter-
assay precision of 4.1 % (CV) and 9.1 % (CV), respectively.
IGF-1 was determined using an ELISA kit (IGF-I DG100,
Lot 267244, R & D Systems, Minneapolis USA). The sensi-
tivity of the assay was 26 ng/mL with intra-assay and inter-
assay precision of 3.5 % (CV) and 8.1 % (CV), respectively.
Insulin was determined using an ELISA kit (Insulin 10-
1200-02, Lot 15719, Mercodia AB, Uppsala Sweden). The
sensitivity of the assay was 0.062 ng/mL with intra-assay
and inter-assay precision of 3.5 % (CV) and 6.9 % (CV),
respectively.
Statistical analyses
Analysis of variance (General Linear Model; Minitab
16, Pennsylvania, USA) was carried out on the data,
with treatment and time as the fixed effects and animal
(ID, sibling relationships and sex) as random effects.
Post-hoc Fisher’s protected least significant difference
analysis was used to test for specific differences be-
tween treatments at each time point. Differences in the
incidence of scouring (diarrhoea) were tested by use of
Chi-square analysis.
Results
Experiment 1
Over the 5 d of the experiment there was a significant
effect of time (P < 0.01) but no effect of treatment or
the interaction of treatment and time on feed intake.
For average daily weight gain (ADG) there was no effect
of time or treatment, but there was a significant inter-
action of treatment and time (P < 0.05), and for feed
conversion ratio (FCR) there was no effect of treatment
or time, but there was a significant interaction of treat-
ment and time (P < 0.05). Specifically, the ADG of the
control group was increased (P < 0.05) compared to the
MCT group on d 2 (343 g/d versus 246 g/d) and d 3
(394 g/d versus 235 g/d). The ADG of the MCT group
was increased (P < 0.05) compared to the control group
(240 g/d versus 160 g/d) on d 5, with the control group’s
ADG decreasing (P < 0.05) by nearly 60 % in the last 2 d
of the experiment (Table 1). The FCR of the MCT group
was about 45 % higher (P < 0.05) and 40 % lower (P < 0.01)
compared to the control group on d 3 and d 5 of the
experiment, respectively. Additionally, it was observed
that 4 of the 8 control pigs had overt diarrhea during the
last 2 d of the experiment, while none of the MCT-treated
pigs were seen to be scouring at any time during the
experiment (Chi-square = 5.33, P < 0.05).
Prior to the start of treatments there was no difference
between the piglet groups in any of the plasma hor-
mones measured (Fig. 1). Overall, there was no effect of
time or treatment on any of the hormones, but there
was a significant effect of the interaction of treatment
and time for ghrelin (P < 0.05), GH (P < 0.05) and insulin
(P < 0.001). Specifically, on d 5 of treatment, the plasma
concentration of ghrelin was increased by 16 % (P <
0.05) in the in the MCT-treated group compared to the
control group. There was no difference in plasma concen-
tration of GH between the treatments on d 5, but there
was a significant difference between the change in GH
concentration between d 0 and d 5 (P < 0.05), with levels
decreasing by 34 % in the control group but increasing by
13 % in the MCT group. Plasma concentrations of insulin
were 4 times lower in the MCT group on d 5 of treatment
(P < 0.001), but there was no difference between treatments
for the plasma concentration of IGF-1.
Post-mortem histological analysis of gut morphology
indicated that villous height in the duodenal and ileal
regions of the small intestine was decreased (P < 0.05) by
about 25 % in the control pigs compared to the MCT-
treated group (Fig. 2). There was no difference in crypt
depth between the treatment groups.
Experiment 2
Daily weight gain, feed intake and feed conversion ratio
were not affected by the inclusion of MCT in the diets,
Table 1 Average daily feed intake (ADFI; mL), average daily gain
(ADG; g/d), feed conversion ratio (FCR; mL/g) and percentage
diarrhoea (% Scour) on each day of treatment for the mixed-sex
weaner pigs in the control group (Cont.; n = 8) and the medium
chain triglyceride supplement (5 % MCT; n = 8) dietary treatments
Item Treatment Day 1 Day 2 Day 3 Day 4 Day 5
ADFI, mL Cont. 1489 1798 2024 2213 2492
MCT 1332 1525 1731 2010 2254
SEMa 163 166 182 129 88
ADG, g/d Cont. 312 343 394 241 160
MCT 247 246* 235* 251 240*
SEMa 40 31 42 37 31
FCR, mL/g Cont. 4.8 5.2 5.1 9.2 15.6
MCT 5.4 6.2 7.4* 8.0 9.4**
SEMa 0.4 0.5 0.6 0.9 1.1
% Scour Cont. 0 0 12.5 50 50
MCT 0 0 0 0* 0*
*= P < 0.05 significance between MCT and control treatment
**= P < 0.01 significance between MCT and control treatment
aSEM = pooled standard error of the mean
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at any of the three levels (1, 3 and 6 %), compared to the
control diet during the entire study (Table 2). Plasma
hormone analysis of pooled blood samples taken at wk
17 (after 21 d on the dietary treatments) indicated that
MCT inclusion increased circulating ghrelin (P <
0.001), GH (P < 0.01) and insulin concentrations (P <
0.05) in a dose-dependent manner, with the 6 % MCT
inclusion rate resulting in a 48 % increase in ghrelin
concentration (P < 0.001), a 130 % increase GH concen-
tration (P < 0.05), and a 33 % increase in insulin concentra-
tion (P < 0.05) compared to controls. MCT inclusion had
no effect on circulating IGF-1 concentration (Fig. 3).
Experiment 3
Daily weight gain, feed intake and feed conversion ratio
were not affected by the inclusion of MCT or CSH in
the diets, compared to the control diet, during the entire
study (Table 3). There was no difference between treat-
ments in the number of days taken to reach slaughter
weight (95 ± 5 kg), or on hot carcass weight or carcass
dressing percentage between the three treatments. There
was a significant difference between the control and
the MCT and CSH treatments for P2 subcutaneous
backfat depth, with MCT-fed pigs having a 19 % lower
(P < 0.01), and the CSH pigs having a 14 % lower back-
fat depth (P < 0.01) compared to the control pigs.
There was an overall difference (P < 0.05) between
treatments in the mean plasma concentration of ghrelin
in the pigs. Specifically, MCT-fed pigs had 26 % higher
concentrations compared to the control pigs (P < 0.05),
and 46 % higher (P < 0.01) concentrations of ghrelin
compared to the CSH pigs (Fig. 4). There was no differ-
ence in GH, IGF-1 or insulin concentrations between
the treatment groups.
Discussion
Experiment 1
This study found that whilst 5 % MCT oil supplemented
for 5 d had no effect on improving feed intake or
growth, it did appear to prevent the diarrhoea-associated
decline in growth rates seen in the control pigs. There
was also evidence to indicate that dietary MCT could be
used to increase the plasma concentration of bioactive
ghrelin. The present findings agree with Nishi et al. [19]
who demonstrated in rats that a 5 % MCT-oil supple-
ment increased the plasma concentration of acylated
(bioactive) ghrelin without changing total ghrelin levels.
Octanoic acid in the diet of the MCT-fed pigs may be
attaching to the third amino acid (serine) of the des-acyl
ghrelin (inactive) peptide, a modification that allows
binding to the ghrelin peptide to its receptor, and hence
is essential for biological activity [24]. Salfen et al. [18]
showed that ghrelin infusion for 5 d positively influenced
weight gain and concomitantly increased GH secretion
Fig. 1 Circulating plasma concentrations of a acyl (bioactive) ghrelin,
b GH, c IGF-1 and d insulin on d 5 of treatment for 30 days old
weaner pigs fed a control (open bars; n = 8) or a 5 % dietary MCT
supplement (black bars; n = 8) in Experiment 1. Values are means ±
S.E.M. * = P < 0.05, *** = P < 0.001 significance between MCT and
control treatment
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in weaner pigs. Although there was an indication in the
present study that circulating GH concentrations were
affected, the response wasn’t of the same magnitude as
found by Salfen et al. [18]. This may be because the
modest increase in bioactive ghrelin levels, by about
16 % in the MCT-fed pigs, wasn’t of the same magnitude
of increase seen with the infusion that caused a 25-fold
increase in total ghrelin levels. Although these two stud-
ies measured different forms of the ghrelin molecule, the
difference in magnitude of response is noteworthy.
Increasing the amount of MCT oil in the diet to achieve
higher bioactive ghrelin levels may be problematic as
high oil contents could result in nutritionally unbalanced
diets. Moreover, a study in neonatal pigs found that
MCT-oil supplements could cause narcotic effects [25]
that may cause young pigs to be less vigorous and thus
increase mortality.
There was a significant decrease in circulating insulin
concentrations in the MCT-fed weaner pigs. The effect
of MCT supplementation on insulin secretion in adult
human and rodent studies is equivocal [26], but the
majority reports a slight hyperinsulinemic response
[27–30]. In the pig, weaning is usually associated with a
decrease in insulin due to the dietary energy deficit
[31]. However, this hypoinsulinemic effect is quickly at-
tenuated once the weaner pig starts eating [32–34]. In-
sulin is very important to the neonatal pig at this stage
of its life as it ensures rapid skeletal muscle protein de-
position [35]. As the MCT diet in the present study
was fed at isoenergetic levels to the control diet, the
reason why insulin levels decreased in the MCT supple-
mented weaner pigs is unknown. It is known though, in
humans, that MCT-based diets produce lower post-
prandial glucose increases than long chain triglyceride
(LCT)-based diets [36, 37], and it has been suggested
that MCT diets improve insulin sensitivity in human
and rodent studies [38, 39].
The MCT-fed pigs had no diarrhea whilst half of the
control pigs were scouring by the end of the 5 d treat-
ment period. The occurrence of scouring in the control
Fig. 2 Representative photomicrographs of small intestine (duodenum) indicating differences in villi height (V) and crypt depth (Cr) after d 5 of
treatment for 31 days old weaner pigs comparing between the two treatments: control (a) and MCT (b) in Experiment 1. Scale bar = 500 μm.
Corresponding measurements of villous height (c) and crypt depth (d) of the three sections of the small intestine (duodenum, jejunum and
ileum) for the control treatment (white bars; n = 8 pigs) and the MCT treatment (black bars; n = 8 pigs). Values are means ± S.E.M. * = P < 0.05
significance between MCT and control treatment
Table 2 Average daily feed intake (ADFI; kg), average daily gain
(ADG; g/d) and feed conversion ratio (FCR; g/g) averaged over
treatment period for male grower-finisher pigs (from 14 to
22 wk of age) in the control group (Cont.; n = 15), the 1 % MCT
supplement (1 % MCT; n= 15), the 3 % MCT supplement (3 % MCT;
n= 15), and the 6 % MCT supplement (6 % MCT; n= 15) dietary
treatments of Experiment 2
Treatment ADFI, kg ADG, kg/d FCR, g/g
Cont. 2.53 1.088 2.33
1 % MCT 2.61 1.089 2.40
3 % MCT 2.63 1.035 2.54
6 % MCT 2.64 1.084 2.44
SEMa 0.06 0.039 0.09
aSEM = pooled standard error of the mean
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pigs was also associated with a decline in growth rates.
When we examined the small intestines of the pigs we
found reduced height of the villi in the duodenal and
ileal regions of the control pigs compared to the MCT
treated pigs. Price and colleagues also showed a benefi-
cial effect of dietary MCT on the intestinal villi in MCT-
fed weaner pigs compared to LCT-fed pigs [40]. The
period following weaning is generally characterised by a
high incidence of intestinal disturbances with diarrhoea
and depression of growth performance being common
[39]. Weaning is often coincidental with a reduction in
villous height in the intestine [19, 41–49] that leaves
fewer and less-differentiated enterocytes on villi available
for the digestion of nutrients [50, 51]. A concomitant
reduction in the capacity of the small intestine to absorb
xylose [51–53], alanine [46, 50] and electrolytes [54] has
also been reported after weaning. Studies have identified
physiological functions for ghrelin apart from stimula-
tion of the somatotropic axis, including cellular prolifer-
ation, apoptosis inhibition and boosting the immune
system [55, 56]. Therefore, it may be plausible to pos-
tulate that the ghrelin-stimulating effect of the MCT
diet in the present study may have been one mechan-
ism to explain the decrease in weaning-associated
problems and improved intestinal functional capacity,
although further studies with larger sample sizes would
be warranted to draw firm conclusions about the effect
of MCT on scouring.
Experiment 2
This study demonstrated that a 6 % MCT dietary incorp-
oration for grower/finisher pigs was optimum (compared
to 1 and 3 %) for increasing the bio-activation of ghrelin
and increasing circulating GH concentrations. However,
there was no effect on growth performance in this study.
A possible reason for the lack of effect may have been that
the level of GH stimulation by the 6 % MCT dietary treat-
ment (about 14 ng/mL, a 2-fold increase compared to the
controls) may not have been sufficient to significantly
affect growth. Hansen et al. [57] found that a daily pST
Table 3 Average daily feed intake (ADFI; kg), average daily gain (ADG; g/d), feed conversion ratio (FCR; g/g) averaged over
treatment period, and days to reach slaughter weight of 95 ± 5 kg from start of experiment (Slaughter; days), subcutaneous P2
backfat depth (P2 Fat; mm), hot carcass weight (HCW; kg) and carcass dressing percentage (Dressing; %) for female grower-finisher
pigs (from 16 to 22 wk of age) in the control group (Cont.; n = 20), the 6 % MCT supplement (MCT; n = 21), and the CSH supplement
(CSH; n = 21) dietary treatments of Experiment 3
Treatment ADFI, kg ADG, kg/d FCR, g/g Slaughter, d P2 Fat, mm HCW, kg Dressing, %
Cont. 2.81 1.061 2.65 37.8 13.1 62.4 67.2
MCT 2.67 0.944 2.83 37.1 10.5** 61.2 66.4
CSH 2.79 1.030 2.71 36.2 11.2** 61.8 66.0
SEMa 0.05 0.052 0.09 1.7 0.6 0.7 2.6
**= P < 0.01 significance between MCT and/or CSH and control treatment
aSEM = pooled standard error of the mean
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Fig. 3 Circulating plasma concentrations of a acyl (bioactive) ghrelin,
b GH, c IGF-1 and d insulin on d 21 of treatment for 17 weeks old
male grower-finisher pigs fed a control (open bars; n = 6) or a 1 %
(light gray bars; n = 6), 3 % (dark gray bars; n = 6), or 6 % (black bars;
n = 6) dietary MCT supplement in Experiment 2. Values are means ±
S.E.M. * = P < 0.05, ** = P < 0.01, *** = P < 0.001 significance between
each of the MCT treatments individually to the control treatment
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(c)
(d)
Fig. 4 Circulating plasma concentrations of a acyl (bioactive) ghrelin, b GH, c IGF-1 and d insulin on d 21 of treatment for 19 weeks old female
grower-finisher pigs fed a control (open bars; n = 7) a 6 % MCT diet (black bars; n = 7) or a CSH diet (gray bars; n = 7) in Experiment 3. Values are
means ± S.E.M. * = P < 0.05 significnce between MCT and/or CSH and control treatment
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(porcine somatotropin) injection in grower pigs that raised
endogenous GH concentrations to about 14 ng/mL had
no effect on muscle protein accretion, whereas Klindt et
al. [58] found that pST implants that raised endogenous
GH concentrations in castrated male pigs to about 30 ng/
mL caused a 22 % increase in average daily gain. Indeed,
the lack of effect of MCT supplementation on IGF-1 levels
in the present study also suggests that GH stimulation
was only modest.
There was a dose-dependent increase in circulating
insulin concentrations in the MCT-fed pigs. As men-
tioned above for Experiment 1, the effect of MCT
supplementation on insulin secretion in other studies is
equivocal [26]. In studies where insulin secretion has
been stimulated it has been ascribed to an indirect effect
of increased ketogenesis on pancreatic function [29].
Another possible mechanistic pathway may be provided
by the insulin-stimulating effect circulating ghrelin has
on pancreatic cells in vitro [59], however studies into the
role of ghrelin in altering insulin secretion are also
equivocal [60]. It is well known that exogenous pST
treatment induces a state of insulin resistance in pigs
resulting in decreased glucose uptake by adipose tissue
[61, 62] and resultant hyperinsulinemia [63].
Experiment 3
The hypothesis that addition of 6 % MCT or CSH to the
diets of grower/finisher pigs would increase endogenous
GH levels, increase the rate of weight gain and improve
feed efficiency, was not supported. There was no effect
of the MCT or CSH diet on plasma GH concentrations,
average daily weight gain or feed intake. However, the
MCT diet did increase circulating levels of active ghrelin
and both the MCT and CSH diets decreased the P2
backfat depth. The reason for the minimal effect on the
somatotropic system is not known, however the lack of
GH stimulation and the concomitant lack of effect on
weight gain and feed intake could be gleaned from the
study by Etherton et al. [64], who found that increases in
plasma GH concentrations to about 25 ng/mL following
pST injection are needed to increase weight gain. Pos-
sible reasons for the lack of a GH response in the MCT
and CSH supplemented animals include: 1) insufficient
stimulation of bioactive ghrelin by MCT and insufficient
suppression of somatostatin by CSH to cause an increase
in GH levels; 2) insufficient numbers of animals to pick up
a modest increase in GH and/or growth stimulation; or 3)
that the MCT and CSH treatments may have initially
increased GH levels, but this effect wasn’t sustained by
the day of blood sampling. In this context, the increase in
daily gain in response to CSH observed by Dunshea [8]
was transient in nature and most apparent in the first
2 wk of treatment.
As was postulated for Experiment 1 (Section 4.1), the
modest stimulation of the somatotropic axis in the MCT-
fed pigs could be due to the modest increase in active
ghrelin levels. In Experiments 2 and 3 the ghrelin levels
only increased to about 260 ng/mL in the 6 % MCT-
treated groups. This level may be insufficient to fully
stimulate the somatotropic axis. However, the decrease in
GH levels were attenuated in Experiment 1 with weaner
pigs (after 5 d of dietary MCT treatment) and increased in
Experiment 2 with male pigs at 17 wk of age (after 3 wk of
dietary MCT treatment), but not in Experiment 3 with fe-
male pigs at 19 wk of age (after 9 wk of dietary MCT
treatment). There are human studies indicating age and
gender differences in ghrelin’s actions [65, 66], so it is pos-
sible that the differences in the present study could be at-
tributed to differences such as these.
The lack of somatotropic response to CSH in the
present study is difficult to explain. While Yang et al. [7]
found that dietary supplementation of CSH, at lower in-
clusion rates to the present study, caused significant in-
creases in daily weight gain in finisher pigs, they also
had no effect on plasma concentrations of GH. However,
Dunshea [8] found that dietary supplementation of CSH,
at the same rate as the present study and with similar
age and gender pigs, caused an increase in daily weight
gain. As somatostatin was not measured in either the
study by Dunshea [8] or in the present study, it is uncer-
tain whether the dose of CSH used actually suppressed
somatostatin secretion, the postulated mode of its action
[5]. An area of research that needs to be investigated is
the dose response to CSH, as there appears to be 10-fold
range of doses being investigated and it may be that
down-regulation of response [8] is more rapid at higher
doses as used in the present study.
There was a significant reduction in P2 backfat depth
with the MCT and CSH treatments. As stated above, this
was not accompanied by an increase in GH levels, so a
GH-stimulated increase in lipolysis, as suggested by re-
searchers using pST injections [67], appears not to
account for this effect. There are a number of possibil-
ities for the reduction in P2 backfat. Firstly, the reduc-
tion in adiposity may be a result of the small decrease in
food intake in the CSH and MCT pigs. However, as this
was not a significant effect it is unlikely to be responsible
for the 14–19 % decrease in P2 backfat depth. Secondly,
there may have been a direct effect of MCT on adipo-
genesis or lipolysis. Well controlled studies in rats fed
MCT via a gastrostomy tube showed that it caused a
decrease in weight, and that this decrease was due to
decreased fat deposition and not loss of lean body mass
[68, 69]. The authors of these studies attributed the ef-
fect to an enhanced metabolic rate. Thirdly, the bioactive
ghrelin increase in the MCT group may have directly
stimulated lipolysis. Ghrelin is capable of stimulating
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lipolysis in rodents and dairy cows [67, 70]. Finally, the
MCT and CSH treatments may have increased the sensi-
tivity of the adipose tissue to the somatotropic/adrener-
gic system [71]. GH is a chronic, homeorhetic effector of
adipose tissue metabolism that has been shown to en-
hance the lipolytic response to an adrenaline challenge
in lactating cows, growing steers, and growing pigs [71].
It is possible that in our study, even though circulating
GH levels were not altered, adrenaline sensitivity of the
adipose tissue may have been altered leading to the
decline in P2 depth. Finally, Yang and colleagues [7],
studying CSH effects in pigs, also found a decrease in
backfat without effects on GH. They stated that the CSH
effects on backfat could have been mediated through the
anabolic effects of glucagon and thyroid hormone, which
increased in their study, on the skeletal muscles and
catabolic effects on the adipose tissue. These mecha-
nisms warrant further investigation.
Conclusions
Evidence was provided in Experiment 1 showing that diet-
ary MCT offers some promise as a means to bio-activate
ghrelin, being the possible mechanism that led to the en-
hanced villous height observed. Although the experimen-
tal period was too short to examine longer-term effects of
MCT on production measures, there was some suggestion
that MCT reduced diarrhoea in the milk-fed pigs and re-
duced the post-weaning decline in GH levels. Incorporat-
ing MCT into diets (milk formulas, solid diets) of pigs
might be a useful aid for the pig industry in terms of de-
creasing weaning-associated problems.
In Experiments 2 and 3 there was no effect of MCT
on growth performance or stimulation of the somatotro-
pic axis, apart from stimulation of circulating bioactive
ghrelin concentration. There was also no effect of CSH
on growth performance or stimulation of the somatotro-
pic axis, indicating that either the design was insufficient
to pick up modest changes in GH levels and weight gain,
or that the effects of MCT and CSH on the decrease in
backfat that was seen are acting independently of soma-
totropic action.
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